TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.7        North America Cardiometabolic Diseases market – By Country

2.           North America Cardiometabolic Diseases Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Cardiometabolic Diseases Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Expert Opinions

5.           North America Cardiometabolic Diseases Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Cardiometabolic Diseases

5.1.2        Innovation in Cardiometabolic Diseases Therapeutics

5.2         Market Restraints

5.2.1        Underdiagnosis of CVDs in Low- and Middle-Income Countries (LMICs)

5.3         Market Opportunities

5.3.1        Technological Advancements in CMD Diagnosis

5.4         Future Trends

5.4.1        Personalized Treatment for CMDs

5.5         Impact Analysis

6.           North America Cardiometabolic Diseases Market – Regional Analysis

6.1         North America Cardiometabolic Diseases Market Revenue Forecast And Analysis

7.           North America Cardiometabolic Diseases Market Analysis – By Type

7.1         Overview

7.2         Cardiometabolic Diseases Market Revenue Share, by Type (2020 and 2028)

7.3         Cardiovascular Disease (CVD)

7.3.1        Overview

7.3.2        Cardiovascular Disease (CVD): Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

7.4         Hypertension

7.4.1        Overview

7.4.2        Hypertension: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

7.5         Type 2 Diabetes

7.5.1        Overview

7.5.2        Type 2 Diabetes: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

7.6         Obesity

7.6.1        Overview

7.6.2        Obesity: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.           North America Cardiometabolic Diseases Market Analysis – By Treatment

8.1         Overview

8.2         Cardiometabolic Diseases Market Revenue Share, by Treatment (2020 and 2028)

8.3         ACE inhibitors

8.3.1        Overview

8.3.2        ACE: Cardiometabolic Diseases Inhibitors Market Revenue and Forecast to 2028 (US$ Mn)

8.4         Diuretics

8.4.1        Overview

8.4.2        Diuretics: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.5         Glucophage

8.5.1        Overview

8.5.2        Glucophage: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.6         Others

8.6.1        Overview

8.6.2        Others: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

9.           North America Cardiometabolic Diseases Market Analysis – By Dosage

9.1         Overview

9.2         Cardiometabolic Diseases Market Revenue Share, by Dosage (2020 and 2028)

9.3         Tablet

9.3.1        Overview

9.3.2        Tablet: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

9.4         Injection

9.4.1        Overview

9.4.2        Injection: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

10.        North America Cardiometabolic Diseases Market Analysis – By Route of Administration

10.1      Overview

10.2      Cardiometabolic Diseases Market Share by Route of Administration 2021 & 2028 (%)

10.3      Oral

10.3.1     Overview

10.3.2     Oral Market Revenue and Forecast to 2028 (US$ Mn)

10.4      Intravenous

10.4.1     Overview

10.4.2     Intravenous Market Revenue and Forecast to 2028 (US$ Mn)

11.        North America Cardiometabolic Diseases Market Analysis – By End User

11.1      Overview

11.2      Cardiometabolic Diseases Market Share by End Users 2020 & 2028 (%)

11.3      Clinic

11.3.1     Overview

11.3.2     Clinic Market Revenue and Forecast to 2028 (US$ Mn)

11.4      Hospital

11.4.1     Overview

11.4.2     Hospital Market Revenue and Forecast to 2028 (US$ Mn)

11.5      Homecare Settings

11.5.1     Overview

11.5.2     Homecare Settings Market Revenue and Forecast to 2028 (US$ Mn)

12.        North America Cardiometabolic Diseases Market Analysis – By Distribution Channel

12.1      Overview

12.2      Cardiometabolic Diseases Market Share by Distribution Channel 2020 & 2028 (%)

12.3      Hospital Pharmacy

12.3.1     Overview

12.3.2     Hospital Pharmacy Market Revenue and Forecast to 2028 (US$ Mn)

12.4      Retail Pharmacy

12.4.1     Overview

12.4.2     Retail Pharmacy Market Revenue and Forecast to 2028 (US$ Mn)

12.5      Online Pharmacy

12.5.1     Overview

12.5.2     Online Pharmacy Market Revenue and Forecast to 2028 (US$ Mn)

13.        North America Cardiometabolic Diseases Market – Geographic Analysis

13.1      North America: Cardiometabolic Diseases Market

13.1.1     Overview

13.1.2     North America: Cardiometabolic Diseases Market - Revenue and Forecast to 2028 (USD Million)

13.1.3     North America Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

13.1.4     North America Cardiometabolic Diseases Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

13.1.5     North America Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

13.1.6     North America Cardiometabolic Diseases Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

13.1.7     North America Cardiometabolic Diseases Market, by End User – Revenue and Forecast to 2028 (USD Million)

13.1.8     North America Cardiometabolic Diseases Market, by Distribution Channel– Revenue and Forecast to 2028 (USD Million)

13.1.9     North America: Cardiometabolic Diseases Market, by Country, 2021 & 2028 (%)

13.1.9.1       US: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (USD Million)

13.1.9.1.1       US: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (USD Million)

13.1.9.1.2       US Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

13.1.9.1.3       US: Cardiometabolic Diseases Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

13.1.9.1.4       US: Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

13.1.9.1.5       US: Cardiometabolic Diseases Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

13.1.9.1.6       US: Cardiometabolic Diseases Market, by End User – Revenue and Forecast to 2028 (USD Million)

13.1.9.1.7       US: Cardiometabolic Diseases Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

13.1.9.2       Canada: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (USD Million)

13.1.9.2.1       Canada: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (USD Million)

13.1.9.2.2       Canada: Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

13.1.9.2.3       Canada: Cardiometabolic Diseases Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

13.1.9.2.4       Canada: Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

13.1.9.2.5       Canada: Cardiometabolic Diseases Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

13.1.9.2.6       Canada: Cardiometabolic Diseases Market, by End User – Revenue and Forecast to 2028 (USD Million)

13.1.9.2.7       Canada: Cardiometabolic Diseases Market, by Distribution Channel– Revenue and Forecast to 2028 (USD Million)

13.1.9.3       Mexico: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (USD Million)

13.1.9.3.1       Mexico: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (USD Million)

13.1.9.3.2       Mexico: Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

13.1.9.3.3       Mexico: Cardiometabolic Diseases Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

13.1.9.3.4       Mexico: Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

13.1.9.3.5       Mexico: Cardiometabolic Diseases Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

13.1.9.3.6       Mexico: Cardiometabolic Diseases Market, by End User – Revenue and Forecast to 2028 (USD Million)

13.1.9.3.7       Mexico: Cardiometabolic Diseases Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

14.        Impact of COVID-19 Pandemic on North America Cardiometabolic Diseases Market

14.1      North America: Impact Assessment of COVID-19 Pandemic

15.        North America Cardiometabolic Diseases Market – Industry Landscape

15.1      Overview

15.2      Growth Strategies in the Cardiometabolic Diseases Market (%)

15.3      Organic Developments

15.3.1     Overview

15.4      Inorganic Developments

15.4.1     Overview

16.        Company Profiles

16.1      Eli Lilly and Company.

16.1.1     Key Facts

16.1.2     Business Description

16.1.3     Products and Services

16.1.4     Financial Overview

16.1.5     SWOT Analysis

16.1.6     Key Developments

16.2      Bayer AG

16.2.1     Key Facts

16.2.2     Business Description

16.2.3     Products and Services

16.2.4     Financial Overview

16.2.5     SWOT Analysis

16.2.6     Key Developments

16.3      Arrowhead Pharmaceuticals, Inc

16.3.1     Key Facts

16.3.2     Business Description

16.3.3     Products and Services

16.3.4     Financial Overview

16.3.5     SWOT Analysis

16.3.6     Key Developments

16.4      Novartis AG

16.4.1     Key Facts

16.4.2     Business Description

16.4.3     Products and Services

16.4.4     Financial Overview

16.4.5     SWOT Analysis

16.4.6     Key Developments

16.5      Boehringer Ingelheim International GmbH

16.5.1     Key Facts

16.5.2     Business Description

16.5.3     Products and Services

16.5.4     Financial Overview

16.5.5     SWOT Analysis

16.5.6     Key Developments

16.6      Novo Nordisk A/S

16.6.1     Key Facts

16.6.2     Business Description

16.6.3     Products and Services

16.6.4     Financial Overview

16.6.5     SWOT Analysis

16.6.6     Key Developments

16.7      AstraZeneca

16.7.1     Key Facts

16.7.2     Business Description

16.7.3     Products and Services

16.7.4     Financial Overview

16.7.5     SWOT Analysis

16.7.6     Key Developments

16.8      Alnylam Pharmaceuticals, Inc.

16.8.1     Key Facts

16.8.2     Business Description

16.8.3     Products and Services

16.8.4     Financial Overview

16.8.5     SWOT Analysis

16.8.6     Key Developments

16.9      Cardax, Inc.

16.9.1     Key Facts

16.9.2     Business Description

16.9.3     Products and Services

16.9.4     Financial Overview

16.9.5     SWOT Analysis

16.9.6     Key Developments

16.10   Kowa Company, Ltd.

16.10.1  Key Facts

16.10.2  Business Description

16.10.3  Products and Services

16.10.4  Financial Overview

16.10.5  SWOT Analysis

16.10.6  Key Developments

17.        Appendix

17.1      About The Insight Partners

17.2      Glossary of Terms

LIST OF TABLES

Table 1.             North America Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 2.             North America Cardiometabolic Diseases Market, by Treatment - Revenue and Forecast to 2028 (USD Million)

Table 3.             North America Cardiometabolic Diseases Market, by Dosage - Revenue and Forecast to 2028 (USD Million)

Table 4.             North America Cardiometabolic Diseases Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)

Table 5.             North America Cardiometabolic Diseases Market, by End User- Revenue and Forecast to 2028 (USD Million)

Table 6.             North America Cardiometabolic Diseases Market, by Distribution Channel- Revenue and Forecast to 2028 (USD Million)

Table 7.             US Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 8.             US Cardiometabolic Diseases Market, by Treatment - Revenue and Forecast to 2028 (USD Million)

Table 9.             US Cardiometabolic Diseases Market, by Dosage - Revenue and Forecast to 2028 (USD Million)

Table 10.          US Cardiometabolic Diseases Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)

Table 11.          US Cardiometabolic Diseases Market, by End User- Revenue and Forecast to 2028 (USD Million)

Table 12.          US Cardiometabolic Diseases Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)

Table 13.          Canada: Cardiometabolic Diseases Market, by Type -Revenue and Forecast to 2028 (USD Million)

Table 14.          Canada: Cardiometabolic Diseases Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 15.          Canada: Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

Table 16.          Canada: Cardiometabolic Diseases Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 17.          Canada: Cardiometabolic Diseases Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 18.          Canada: Cardiometabolic Diseases Market, by Distribution Channel– Revenue and Forecast to 2028 (USD Million)

Table 19.          Mexico Cardiometabolic Diseases Market, by Type -Revenue and Forecast to 2028 (USD Million)

Table 20.          Mexico Cardiometabolic Diseases Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 21.          Mexico Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

Table 22.          Mexico Cardiometabolic Diseases Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 23.          Mexico Cardiometabolic Diseases Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 24.          Mexico Cardiometabolic Diseases Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 25.          Organic Developments in the Cardiometabolic Diseases Market

Table 26.          Inorganic Developments in the Cardiometabolic Diseases Market

Table 27.          Glossary of Terms, North America Cardiometabolic Diseases Market

LIST OF FIGURES

Figure 1.           North America Cardiometabolic Diseases Market Segmentation

Figure 2.           North America Cardiometabolic Diseases Market Overview

Figure 3.           Cardiovascular Disease (CVD) Segment Held Largest Share Type of North America Cardiometabolic Diseases Market

Figure 4.           North America Cardiometabolic Diseases Market – Leading Country Markets (US$ Million)

Figure 5.           North America Cardiometabolic Diseases Market, Industry Landscape

Figure 6.           North America PEST Analysis

Figure 7.           North America Cardiometabolic Diseases Market Impact Analysis of Drivers and Restraints

Figure 8.           North America Cardiometabolic Diseases Market – Revenue Forecast And Analysis – 2020- 2028

Figure 9.           Cardiometabolic Diseases Market Revenue Share, by Type (2020 and 2028)

Figure 10.        Cardiovascular Disease (CVD): Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11.        Hypertension: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12.        Type 2 Diabetes: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13.        Obesity: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14.        Cardiometabolic Diseases Market Revenue Share, by Treatment (2020 and 2028)

Figure 15.        ACE inhibitors: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16.        Diuretics: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17.        Glucophage: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18.        Others: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19.        Cardiometabolic Diseases Market Revenue Share, by Dosage (2020 and 2028)

Figure 20.        Tablet: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21.        Injection: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22.        Cardiometabolic Diseases Market Share by Route of Administration 2021 & 2028 (%)

Figure 23.        Oral Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24.        Intravenous Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25.        Cardiometabolic Diseases Market Share by End Users 2020 & 2028 (%)

Figure 26.        Clinic Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27.        Hospital Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28.        Homecare Settings Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29.        Cardiometabolic Diseases Market Share by Distribution Channel 2020 & 2028 (%)

Figure 30.        Hospital Pharmacy Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 31.        Retail Pharmacy Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 32.        Online Pharmacy Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 33.        North America: Cardiometabolic Diseases Market, by Key Country – Revenue (2021) (USD Million)

Figure 34.        North America Cardiometabolic Diseases Market Revenue and Forecast to 2028 (USD Million)

Figure 35.        North America: Cardiometabolic Diseases Market, by Country, 2021 & 2028 (%)

Figure 36.        US: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (USD Million)

Figure 37.        Canada: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (USD Million)

Figure 38.        Mexico: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (USD Million)

Figure 39.        Impact of COVID-19 Pandemic on North America Cardiometabolic Diseases Market

Figure 40.        Growth Strategies in the Cardiometabolic Diseases Market (%)

S